ANDA User Fee Proposal From Industry Relies Heavily On Establishment Fees
The plan would require 80% of generic drug user fee revenue to come from finished dosage manufacturers and 20% from API manufacturers.
The plan would require 80% of generic drug user fee revenue to come from finished dosage manufacturers and 20% from API manufacturers.